Nippon Jibiinkoka Gakkai Kaiho
Online ISSN : 1883-0854
Print ISSN : 0030-6622
ISSN-L : 0030-6622
Search
Advanced search
OR
Browse
Search
Volume 116, Issue 2
Displaying 1-12 of 12 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Review article
Original article
  • Clinical Analysis of 1059 Patients with Taste Disorders
    Akiko Sakaguchi, Tomomi Nin, Hideki Oka, Emi Maeda, Atsushi Negoro, Ma ...
    2013 Volume 116 Issue 2 Pages 77-82
    Published: 2013
    Released on J-STAGE: April 11, 2013
    DOIhttps://doi.org/10.3950/jibiinkoka.116.77
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    Taste disorders are caused by several factors, and there have been few reports concerning the clinical course of taste disorders. In this study, patients with taste disorders were classified into 10 groups according to causes, and they were retrospectively studied in terms of therapeutic effects. In total, 1059 patients (412 men and 647 women, mean age: 60.0 years) who complained of taste disorders were reviewed in our clinic. The patients were asked detailed questions about their history of symptoms, and their emotional status was assessed using a self-rating depression scale. In all subjects, taste functions were measured by electrogustometry (EGM) and filter paper disks (FPD). The grades of their symptoms were assessed with a visual analogue scale (VAS). In addition, the levels of serum iron, copper, and zinc were examined. The patients were treated with zinc sulfate, polaprezinc, iron preparation, herbal medicine, and minor tranquilizers according to the factors causing the taste disorders. The most frequent cause was idiopathic taste disorder (192 cases, 18.2%), the second was psychogenic (186 cases, 17.6%), and the third was drug-induced (179 cases, 16.9%). The recovery rate of the symptoms was 64/92 (70.2%) in post-common cold, 31/35 (88.6%) in iron deficiency, and 85/116 (73.3%) in zinc deficiency. In these groups, the rates of recoveries were better than in the other groups. The recovery period in drug-induced taste disorders was approximately twice as long as the recovery period in the other groups. In the patients who were able to start treatment within 6 months from the onset of taste disorder, the recovery rate was significantly higher and the therapeutic period was significantly shorter than in those who had the disorders for more than 6 months (p<0.05, respectively).
    View full abstract
    Download PDF (860K)
  • Evaluation of Hearing Results after Tympanoplasty according to the Classification of the Development Degree for Pars Flaccid Cholesteatoma
    Tadahiko Wada, Michitaka Iwanaga, Nobuhiro Hakuba, Yasuyuki Hiratsuka, ...
    2013 Volume 116 Issue 2 Pages 83-90
    Published: 2013
    Released on J-STAGE: April 11, 2013
    DOIhttps://doi.org/10.3950/jibiinkoka.116.83
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    Our surgical treatment for middle ear cholesteatoma is based on the following 2 concepts: (1) Preservation of the physiological morphology and function of the middle ear, that is, maximal preservation of the posterior wall of the external auditory meatus and the middle ear mucosa and (2) Careful resection of the matrix membrane of the cholesteatoma through the continuity of the matrix membrane. In case the cholesteatoma matrix membrane is ruptured, a staged operation should be performed to prevent the development of residual cholesteatoma from the residual matrix. In this study, we classified a total of 238 cases of the pars flaccida cholesteatoma primary operated on Osaka Red Cross Hospital between January 2006 and March 2008 according to the Classification and Staging of Cholesteatoma proposed in 2010. The age of the patients ranged from 4 to 79 years (average: 49.8 years) and there were123 males and 115 females. Follow up ranged from 1 year to 5 years with a mean follow-up period of 47.8 months. Regarding the stage, 38 (16.0%) ears had stage I cholesteatoma, 155 (65.1%) ears had stage II, and 45 (18.9%) ears had stage III. The successful outcome rate was 97.4% for stage I, 78.7% for stage II and 60.0% for stage III. The rate of the residue and the postoperative recurrence was 2.5% and 4.2%.
    View full abstract
    Download PDF (1686K)
  • Two Cases of Pediatric Psychogenic Gait Disturbance
    Fumiyuki Goto, Noriko Morimoto, Hidenobu Taiji
    2013 Volume 116 Issue 2 Pages 91-96
    Published: 2013
    Released on J-STAGE: April 11, 2013
    DOIhttps://doi.org/10.3950/jibiinkoka.116.91
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    We report herein on 2 cases of pediatric psychogenic gait disturbance. Both patients (boys) were aged 10 years. Patient 1 had psychogenic fever and psychogenic visual disturbance. His symptoms improved after 4 months. Patient 2 had headache and general fatigue and was subfebrile. His symptoms disappeared after 5 months. Pediatric psychogenic gait disturbance is rare, and it is important to understand the clinical characteristics of the affected patients. In most cases, treatment can be time-consuming. To treat these patients, it is important to rule out organic disorders. A diagnosis of psychogenic gait disturbance should be made on the basis of the clinical characteristics of the disorder, such as (1) momentary fluctuations of stance and gait, often in response to suggestions; (2) excessive slowness or hesitation of locomotion incompatible with neurological disease; and (3) uneconomic postures with wastage of muscle energy. These symptoms typically improve in 4-5 months.
    View full abstract
    Download PDF (1082K)
  • Treatments for Otorhinolaryngological Patients with Psychiatric Disorders
    Ayako Nishio, Takuro Sumi, Masato Yamada, Yuko Kuwahata, M.D.
    2013 Volume 116 Issue 2 Pages 97-102
    Published: 2013
    Released on J-STAGE: April 11, 2013
    DOIhttps://doi.org/10.3950/jibiinkoka.116.97
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    There are few systems in place for patients with psychiatric disorders who need treatments for physical complications. In Tokyo, “The Tokyo metropolitan psychiatric emergency system” was established in 1981, and Ome Municipal General Hospital participated in it. Under this system, fifteen patients with psychiatric disorders were treated for otorhinolaryngological diseases in our department from April 2005 to March 2011. We reviewed the fifteen patients. The coexisting psychiatric disorders were schizophrenia in twelve patients, and mental retardation, Korsakoff's syndrome, and Alzheimer's dementia in one patient each, respectively. All the patients had been receiving psychiatric treatment. The otorhinolaryngological diseases were head and neck cancer in nine patients, chronic sinusitis in three patients, and benign salivary gland tumor, cholesteatoma, and epistaxis in one patient each, respectively. Among the fifteen patients, thirteen could complete their treatment, but two dropped out due to exacerbation of their psychiatric symptoms.
    The therapeutic course is uncertain in otorhinolaryngological diseases occurring concomitantly with psychiatric disorders, especially in head and neck cancer, because it may be difficult to prioritize the problem when determining the treatment options and delivering the treatment. Thus, we should treat patients with psychiatric disorders carefully on a case-by-case basis depending on their psychiatric symptoms. It is also important to cooperate with psychiatrists and patients' families.
    View full abstract
    Download PDF (412K)
Skill up lecture
Lifelong learning for Board Certified Otorhinolaryngologist
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top